PTC today announced it will demonstrate how Bobcat, a leading global manufacturer of compact equipment, can leverage the ...
PTC Therapeutics has abandoned its latest attempt to secure FDA approval for Duchenne muscular dystrophy (DMD) treatment Translarna, after the FDA said it was unlikely to approve the drug based on the ...
PTC Therapeutic's Upstaza gene therapy for patients with genetic disorder AADC deficiency has been recommended for approval in the EU, setting up another test of the commercial prospects for gene ...
Great to see everybody. Thank you for coming in to see us talk to Neil from PTC. Neil, thank you very much for being here. Many years now at the conference. I always enjoy this conversation. Let's ...
The co-hosts of "The View" erupted on Thursday after conservative guest host Savannah Chrisley defended President Donald Trump against those who call him a racist, including co-host Sunny Hostin. The ...
The FDA stated that ataluren data lacked the substantial evidence of effectiveness needed for approval, leading PTC Therapeutics to withdraw its NDA. Following discussions with the Food and Drug ...
The withdrawal is due to data shared from FDA reflecting that data included in the NDA submission is unlikely to meet the required threshold of evidence. PTC Therapeutics withdrew its New Drug ...
Morphy Richards OFR Room Heater, 09 Fin 2000 Watts Oil Filled Room Heater , ISI Approved (OFR 9 Grey)View Details Every product we recommend is chosen through a combination of Primary Research and ...
California-based Palo Alto Investors increased its stake in PTCT by 456,144 shares in the third quarter, adding approximately $33.1 million in value. The change represents approximately 4.4% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results